These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 9493572

  • 1. Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group.
    van den Belt AG, Bossuyt PM, Prins MH, Gallus AS, Büller HR.
    Thromb Haemost; 1998 Feb; 79(2):259-63. PubMed ID: 9493572
    [Abstract] [Full Text] [Related]

  • 2. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.
    Koopman MM, Prandoni P, Piovella F, Ockelford PA, Brandjes DP, van der Meer J, Gallus AS, Simonneau G, Chesterman CH, Prins MH.
    N Engl J Med; 1996 Mar 14; 334(11):682-7. PubMed ID: 8594426
    [Abstract] [Full Text] [Related]

  • 3. [Health care economics evaluation of inpatient treatment of venous thrombosis with unfractionated heparin versus subcutaneous low molecular weight heparin at home].
    Osterkorn D, Schramm W, Szucs T.
    Med Klin (Munich); 1996 Sep 15; 91(9):607-9. PubMed ID: 8984321
    [Abstract] [Full Text] [Related]

  • 4. Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective.
    Hull RD, Raskob GE, Rosenbloom D, Pineo GF, Lerner RG, Gafni A, Trowbridge AA, Elliott CG, Green D, Feinglass J.
    Arch Intern Med; 1997 Feb 10; 157(3):289-94. PubMed ID: 9040295
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of ambulatory and inpatient treatment of acute deep venous thrombosis of the leg: subjective and economic aspects].
    Frank D, Blättler W.
    Schweiz Med Wochenschr; 1998 Sep 05; 128(36):1328-33. PubMed ID: 9784675
    [Abstract] [Full Text] [Related]

  • 6. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.
    Hull RD, Raskob GE, Pineo GF, Green D, Trowbridge AA, Elliott CG, Lerner RG, Hall J, Sparling T, Brettell HR.
    N Engl J Med; 1992 Apr 09; 326(15):975-82. PubMed ID: 1545850
    [Abstract] [Full Text] [Related]

  • 7. Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism.
    Grau E, Tenias JM, Real E, Medrano J, Ferrer R, Pastor E, Selfa S.
    Am J Hematol; 2001 May 09; 67(1):10-4. PubMed ID: 11279651
    [Abstract] [Full Text] [Related]

  • 8. [Therapy of thromboses with low-molecular-weight heparins].
    Haas S, Haas P.
    Wien Med Wochenschr; 1999 May 09; 149(2-4):39-45; discussion 45. PubMed ID: 10378321
    [Abstract] [Full Text] [Related]

  • 9. Low-molecular-weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical results.
    Crowther M, Hirsh J.
    Semin Thromb Hemost; 1997 May 09; 23(1):77-81. PubMed ID: 9156414
    [Abstract] [Full Text] [Related]

  • 10. Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
    Raskob GE.
    Curr Opin Pulm Med; 1996 Jul 09; 2(4):305-10. PubMed ID: 9363157
    [Abstract] [Full Text] [Related]

  • 11. Low molecular weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical results.
    Hirsh J, Crowther M.
    Thromb Haemost; 1997 Jul 09; 78(1):689-92. PubMed ID: 9198240
    [Abstract] [Full Text] [Related]

  • 12. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J, Riess H, Büller HR, Brom J, Weidinger G, Huisman MV.
    Haematologica; 2003 Oct 09; 88(10):1157-62. PubMed ID: 14555312
    [Abstract] [Full Text] [Related]

  • 13. The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy.
    Rodger MA, Gagné-Rodger C, Howley HE, Carrier M, Coyle D, Wells PS.
    Thromb Res; 2003 Oct 09; 112(1-2):13-8. PubMed ID: 15013267
    [Abstract] [Full Text] [Related]

  • 14. Outpatient treatment of deep vein thrombosis with LMWH.
    Koopman MM.
    Wien Med Wochenschr; 1999 Oct 09; 149(2-4):46-9; discussion 49. PubMed ID: 10378322
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis.
    Rodger M, Bredeson C, Wells PS, Beck J, Kearns B, Huebsch LB.
    CMAJ; 1998 Oct 20; 159(8):931-8. PubMed ID: 9834718
    [Abstract] [Full Text] [Related]

  • 16. Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation.
    Huse DM, Cummins G, Taylor DC, Russell MW.
    Am J Manag Care; 2002 Jan 20; 8(1 Suppl):S10-6. PubMed ID: 11822346
    [Abstract] [Full Text] [Related]

  • 17. Low-molecular-weight heparin in outpatient treatment of DVT.
    Yeager BF, Matheny SC.
    Am Fam Physician; 1999 Feb 15; 59(4):945-52. PubMed ID: 10068716
    [Abstract] [Full Text] [Related]

  • 18. An outpatient program to treat deep venous thrombosis with low-molecular-weight heparin.
    Pearson SD, Blair R, Halpert A, Eddy E, Mckean S.
    Eff Clin Pract; 1999 Feb 15; 2(5):210-7. PubMed ID: 10623053
    [Abstract] [Full Text] [Related]

  • 19. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
    Ramacciotti E, Araújo GR, Lastoria S, Maffei FH, Karaoglan de Moura L, Michaelis W, Sandri JL, Dietrich-Neto F, CLETRAT Investigators.
    Thromb Res; 2004 Feb 15; 114(3):149-53. PubMed ID: 15342210
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.